Data Supplement
- Supplemental Data -
Supplementary Table 1 - Comparison of Plasma Concentrations of Selected Endogenous Metabolites between a Single or Combined IV Administration of PROB (40 mg/kg) and FSM with a Single IV Administration of 2 mg/kg FSM in 3 Cynomolgus Monkeys
Supplementary Table 2 - Comparison of Inhibition Potency of PROB Towards Various Human Transporters
Supplementary Figure 1 - Time course of uptake of PDA (1 μM) by OAT1 (A) and OAT3 (B), and HVA (5 μM) by OAT1
Supplementary Figure 2 - Profiling of the transport of PDA and HVA by major drug transporters expressed at the basolateral membrane of human hepatocytes